Thalassemia Treatment Market, Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Thalassemia Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Thalassemia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Thalassemia Treatment Overall Market Size
2.1 Global Thalassemia Treatment Market Size: 2021 VS 2028
2.2 Global Thalassemia Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Thalassemia Treatment Players in Global Market
3.2 Top Global Thalassemia Treatment Companies Ranked by Revenue
3.3 Global Thalassemia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Thalassemia Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Thalassemia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Thalassemia Treatment Players in Global Market
3.6.1 List of Global Tier 1 Thalassemia Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Thalassemia Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Thalassemia Treatment Market Size Markets, 2021 & 2028
4.1.2 DFO
4.1.3 DFP
4.1.4 DFX
4.1.5 Others
4.2 By Type - Global Thalassemia Treatment Revenue & Forecasts
4.2.1 By Type - Global Thalassemia Treatment Revenue, 2017-2022
4.2.2 By Type - Global Thalassemia Treatment Revenue, 2023-2028
4.2.3 By Type - Global Thalassemia Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Thalassemia Treatment Market Size, 2021 & 2028
5.1.2 Children and Teenagers
5.1.3 Adults
5.2 By Application - Global Thalassemia Treatment Revenue & Forecasts
5.2.1 By Application - Global Thalassemia Treatment Revenue, 2017-2022
5.2.2 By Application - Global Thalassemia Treatment Revenue, 2023-2028
5.2.3 By Application - Global Thalassemia Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Thalassemia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Thalassemia Treatment Revenue & Forecasts
6.2.1 By Region - Global Thalassemia Treatment Revenue, 2017-2022
6.2.2 By Region - Global Thalassemia Treatment Revenue, 2023-2028
6.2.3 By Region - Global Thalassemia Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Thalassemia Treatment Revenue, 2017-2028
6.3.2 US Thalassemia Treatment Market Size, 2017-2028
6.3.3 Canada Thalassemia Treatment Market Size, 2017-2028
6.3.4 Mexico Thalassemia Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Thalassemia Treatment Revenue, 2017-2028
6.4.2 Germany Thalassemia Treatment Market Size, 2017-2028
6.4.3 France Thalassemia Treatment Market Size, 2017-2028
6.4.4 U.K. Thalassemia Treatment Market Size, 2017-2028
6.4.5 Italy Thalassemia Treatment Market Size, 2017-2028
6.4.6 Russia Thalassemia Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Thalassemia Treatment Market Size, 2017-2028
6.4.8 Benelux Thalassemia Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Thalassemia Treatment Revenue, 2017-2028
6.5.2 China Thalassemia Treatment Market Size, 2017-2028
6.5.3 Japan Thalassemia Treatment Market Size, 2017-2028
6.5.4 South Korea Thalassemia Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Thalassemia Treatment Market Size, 2017-2028
6.5.6 India Thalassemia Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Thalassemia Treatment Revenue, 2017-2028
6.6.2 Brazil Thalassemia Treatment Market Size, 2017-2028
6.6.3 Argentina Thalassemia Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Thalassemia Treatment Revenue, 2017-2028
6.7.2 Turkey Thalassemia Treatment Market Size, 2017-2028
6.7.3 Israel Thalassemia Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Thalassemia Treatment Market Size, 2017-2028
6.7.5 UAE Thalassemia Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Thalassemia Treatment Major Product Offerings
7.1.4 Novartis Thalassemia Treatment Revenue in Global Market (2017-2022)
7.1.5 Novartis Key News
7.2 Shire PLC
7.2.1 Shire PLC Corporate Summary
7.2.2 Shire PLC Business Overview
7.2.3 Shire PLC Thalassemia Treatment Major Product Offerings
7.2.4 Shire PLC Thalassemia Treatment Revenue in Global Market (2017-2022)
7.2.5 Shire PLC Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Thalassemia Treatment Major Product Offerings
7.3.4 GlaxoSmithKline Thalassemia Treatment Revenue in Global Market (2017-2022)
7.3.5 GlaxoSmithKline Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Thalassemia Treatment Major Product Offerings
7.4.4 Johnson & Johnson Thalassemia Treatment Revenue in Global Market (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Merck
7.5.1 Merck Corporate Summary
7.5.2 Merck Business Overview
7.5.3 Merck Thalassemia Treatment Major Product Offerings
7.5.4 Merck Thalassemia Treatment Revenue in Global Market (2017-2022)
7.5.5 Merck Key News
7.6 Acceleron Pharma
7.6.1 Acceleron Pharma Corporate Summary
7.6.2 Acceleron Pharma Business Overview
7.6.3 Acceleron Pharma Thalassemia Treatment Major Product Offerings
7.6.4 Acceleron Pharma Thalassemia Treatment Revenue in Global Market (2017-2022)
7.6.5 Acceleron Pharma Key News
7.7 Bellicum Pharmaceuticals
7.7.1 Bellicum Pharmaceuticals Corporate Summary
7.7.2 Bellicum Pharmaceuticals Business Overview
7.7.3 Bellicum Pharmaceuticals Thalassemia Treatment Major Product Offerings
7.7.4 Bellicum Pharmaceuticals Thalassemia Treatment Revenue in Global Market (2017-2022)
7.7.5 Bellicum Pharmaceuticals Key News
7.8 Bluebird Bio
7.8.1 Bluebird Bio Corporate Summary
7.8.2 Bluebird Bio Business Overview
7.8.3 Bluebird Bio Thalassemia Treatment Major Product Offerings
7.8.4 Bluebird Bio Thalassemia Treatment Revenue in Global Market (2017-2022)
7.8.5 Bluebird Bio Key News
7.9 Celgene Corporation
7.9.1 Celgene Corporation Corporate Summary
7.9.2 Celgene Corporation Business Overview
7.9.3 Celgene Corporation Thalassemia Treatment Major Product Offerings
7.9.4 Celgene Corporation Thalassemia Treatment Revenue in Global Market (2017-2022)
7.9.5 Celgene Corporation Key News
7.10 Gamida Cell
7.10.1 Gamida Cell Corporate Summary
7.10.2 Gamida Cell Business Overview
7.10.3 Gamida Cell Thalassemia Treatment Major Product Offerings
7.10.4 Gamida Cell Thalassemia Treatment Revenue in Global Market (2017-2022)
7.10.5 Gamida Cell Key News
7.11 Incyte Corporation
7.11.1 Incyte Corporation Corporate Summary
7.11.2 Incyte Corporation Business Overview
7.11.3 Incyte Corporation Thalassemia Treatment Major Product Offerings
7.11.4 Incyte Corporation Thalassemia Treatment Revenue in Global Market (2017-2022)
7.11.5 Incyte Corporation Key News
7.12 Kiadis Pharma
7.12.1 Kiadis Pharma Corporate Summary
7.12.2 Kiadis Pharma Business Overview
7.12.3 Kiadis Pharma Thalassemia Treatment Major Product Offerings
7.12.4 Kiadis Pharma Thalassemia Treatment Revenue in Global Market (2017-2022)
7.12.5 Kiadis Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Thalassemia Treatment Market Opportunities & Trends in Global Market
Table 2. Thalassemia Treatment Market Drivers in Global Market
Table 3. Thalassemia Treatment Market Restraints in Global Market
Table 4. Key Players of Thalassemia Treatment in Global Market
Table 5. Top Thalassemia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Thalassemia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Thalassemia Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Thalassemia Treatment Product Type
Table 9. List of Global Tier 1 Thalassemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Thalassemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Thalassemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Thalassemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Thalassemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Thalassemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Thalassemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Thalassemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Thalassemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Thalassemia Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Thalassemia Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Thalassemia Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Thalassemia Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Thalassemia Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Thalassemia Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Thalassemia Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Thalassemia Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Thalassemia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Thalassemia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Thalassemia Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Thalassemia Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Thalassemia Treatment Product Offerings
Table 32. Novartis Thalassemia Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Shire PLC Corporate Summary
Table 34. Shire PLC Thalassemia Treatment Product Offerings
Table 35. Shire PLC Thalassemia Treatment Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Thalassemia Treatment Product Offerings
Table 38. GlaxoSmithKline Thalassemia Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Thalassemia Treatment Product Offerings
Table 41. Johnson & Johnson Thalassemia Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Thalassemia Treatment Product Offerings
Table 44. Merck Thalassemia Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Acceleron Pharma Corporate Summary
Table 46. Acceleron Pharma Thalassemia Treatment Product Offerings
Table 47. Acceleron Pharma Thalassemia Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Bellicum Pharmaceuticals Corporate Summary
Table 49. Bellicum Pharmaceuticals Thalassemia Treatment Product Offerings
Table 50. Bellicum Pharmaceuticals Thalassemia Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Bluebird Bio Corporate Summary
Table 52. Bluebird Bio Thalassemia Treatment Product Offerings
Table 53. Bluebird Bio Thalassemia Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Celgene Corporation Corporate Summary
Table 55. Celgene Corporation Thalassemia Treatment Product Offerings
Table 56. Celgene Corporation Thalassemia Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Gamida Cell Corporate Summary
Table 58. Gamida Cell Thalassemia Treatment Product Offerings
Table 59. Gamida Cell Thalassemia Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Incyte Corporation Corporate Summary
Table 61. Incyte Corporation Thalassemia Treatment Product Offerings
Table 62. Incyte Corporation Thalassemia Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Kiadis Pharma Corporate Summary
Table 64. Kiadis Pharma Thalassemia Treatment Product Offerings
Table 65. Kiadis Pharma Thalassemia Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Thalassemia Treatment Segment by Type in 2021
Figure 2. Thalassemia Treatment Segment by Application in 2021
Figure 3. Global Thalassemia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Thalassemia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Thalassemia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Thalassemia Treatment Revenue in 2021
Figure 8. By Type - Global Thalassemia Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Thalassemia Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Thalassemia Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Thalassemia Treatment Revenue Market Share, 2017-2028
Figure 12. US Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Thalassemia Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Thalassemia Treatment Revenue Market Share, 2017-2028
Figure 24. China Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Thalassemia Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Thalassemia Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Thalassemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Thalassemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Shire PLC Thalassemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Thalassemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Thalassemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Thalassemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Acceleron Pharma Thalassemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bellicum Pharmaceuticals Thalassemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bluebird Bio Thalassemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Celgene Corporation Thalassemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Gamida Cell Thalassemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Incyte Corporation Thalassemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Kiadis Pharma Thalassemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)